Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
The Market Swooned, but Sarepta Therapeutics Soared in August
Motley Fool
Sat, 09/5/15 - 11:05 am
Sarepta Therapeutics
eteplirsen
Sarepta snags priority review status to keep pace with BioMarin in DMD race
Fierce Biotech
Wed, 08/26/15 - 09:28 am
Sarepta Therapeutics
priority review
Duchenne Muscular Dystrophy
FDA
eteplirsen
drisapersen
Biomarin
Three Bay State biotechs that bucked the recent sell-off — and why
Bizjournals.com
Sat, 08/22/15 - 08:46 am
biotech
Inotek
Eleven Biotherapeutics
Sarepta Therapeutics
Post-Sarepta, Art Krieg gets $20M to take a shot at an immuno-oncology Checkmate
Fierce Biotech
Wed, 08/12/15 - 09:13 am
Sarepta Therapeutics
Checkmate Pharmaceuticals
immuno-oncology
Sarepta Therapeutics reports 2Q loss
Yahoo/AP
Thu, 08/6/15 - 10:25 am
earnings
Sarepta Therapeutics
FDA Closing In on November Expert Panel Date for BioMarin, Sarepta Drugs
TheStreet.com
Mon, 07/20/15 - 02:37 pm
FDA
Biomarin
advisory panels
eteplirsen
Sarepta Therapeutics
drisapersen
Duchenne Muscular Dystrophy
Sarepta Therapeutics One Step Closer to Drug Approval
Investopedia
Fri, 07/3/15 - 08:00 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
Tue, 06/30/15 - 06:13 pm
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
Sarepta Submits DMD Drug for FDA Approval Review
TheStreet.com
Mon, 06/29/15 - 10:48 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
FDA Tells Sarepta Therapeutics: Come on Down With Your DMD Drug!
TheStreet.com
Tue, 05/19/15 - 05:02 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Why BioMarin’s New Drug Application is Good News for Sarepta Therapuetics
Fierce Pharma Marketing
Wed, 05/6/15 - 11:44 am
Biomarin
Sarepta Therapeutics
drisapersen
Duchenne Muscular Dystrophy
Sarepta Therapeutics CEO Chris Garabedian resigns
Marketwatch
Wed, 04/1/15 - 10:35 am
Sarepta Therapeutics
Chris Garabedian
Sarepta Therapeutics reports 4Q loss
Yahoo/AP
Thu, 02/26/15 - 09:57 am
Sarepta Therapeutics
earnings
BioMarin CEO Angers Sarepta CEO With Slides Comparing Trial Data
WSJ Pharmalot
Sat, 01/17/15 - 11:01 am
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biotech Rivalry Gets Nasty in Mudslinging Battle Over Data
Bloomberg
Thu, 01/15/15 - 09:28 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
Sarepta's CEO can reverse the company's downward trend with a stellar presentation tomorrow
Bizjournals.com
Thu, 01/15/15 - 08:55 am
Sarepta Therapeutics
Pharma CEOs
Chris Garabedian
JPMHC 2015
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Biogen Idec
Bluebird Bio
Arrowhead Research
Vertex Pharmaceuticals
Cempra
CTI BioPharma
Gilead Sciences
Merck
Bristol-Myers Squibb
Sarepta Therapeutics
Neurocrine Biosciences
A ‘Strange Back and Forth’ Between Sarepta and the FDA
WSJ Pharmalot
Fri, 10/31/14 - 02:13 pm
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta timeline delayed on muscular dystrophy drug
CNBC
Mon, 10/27/14 - 08:51 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Is Sarepta Therapeutics Inc. (NASDAQ:SRPT) about to go bankrupt?
wallstreet.org
Sun, 10/26/14 - 10:24 am
Sarepta Therapeutics
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »